These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19955827)

  • 1. Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: a pilot study.
    Duranay M; Kanbay M; Akay H; Unverdi S; Sürer H; Altay M; Kirbaş I; Covic A; Zoccali C
    Nephron Clin Pract; 2010; 114(3):c213-7. PubMed ID: 19955827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of acute functional injury following percutaneous renal artery intervention.
    Davies MG; Saad WE; Peden EK; Mohiuddin IT; Naoum JJ; Lumsden AB
    Ann Vasc Surg; 2008 Nov; 22(6):783-9. PubMed ID: 18692990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.
    Pires MJ; Rodríguez-Peña AB; Arévalo M; Cenador B; Evangelista S; Esteller A; Sánchez-Rodríguez A; Colaço A; López-Novoa JM
    J Hypertens; 2007 Dec; 25(12):2486-96. PubMed ID: 17984671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization of renal artery stenosis in patients with renal insufficiency.
    Dejani H; Eisen TD; Finkelstein FO
    Am J Kidney Dis; 2000 Oct; 36(4):752-8. PubMed ID: 11007677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of excimer laser debulking for critical lesions unsuitable for standard renal angioplasty.
    Topaz O; Polkampally PR; Topaz A; Polkampally CR; Jara J; Rizk M; McDowell K; Feldman G
    Lasers Surg Med; 2009 Nov; 41(9):622-7. PubMed ID: 19816915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis.
    Cheung CM; Chrysochou C; Shurrab AE; Buckley DL; Cowie A; Kalra PA
    Nephrol Dial Transplant; 2010 Apr; 25(4):1133-40. PubMed ID: 20028827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis.
    Kane GC; Xu N; Mistrik E; Roubicek T; Stanson AW; Garovic VD
    Nephrol Dial Transplant; 2010 Mar; 25(3):813-20. PubMed ID: 19666661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
    Dobre D; van Veldhuisen DJ; Mordenti G; Vintila M; Haaijer-Ruskamp FM; Coats AJ; Poole-Wilson PA; Flather MD;
    Am Heart J; 2007 Jul; 154(1):109-15. PubMed ID: 17584562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy.
    Rocha-Singh KJ; Ahuja RK; Sung CH; Rutherford J
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):135-41. PubMed ID: 12357507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ischemic renal disease: revascularization or conservative treatment?].
    Rodríguez Jornet A; Ibeas J; Ribera L; Real J; Perendreu J; Falcó J; Vallespín J; Allegué N; Giménez Gaibar A; García García M
    Nefrologia; 2005; 25(3):258-68. PubMed ID: 16053007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angioplasty of the renal artery: antihypertensive and renal effects.
    Morganti A
    J Nephrol; 2000; 13 Suppl 3():S28-33. PubMed ID: 11132030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nebivolol on levels of serum nitric oxide, plasma von Willebrand factor and exercise stress testing parameters in hypertensive and ischemic heart disease patients.
    Kobusiak-Prokopowicz M; Jołda-Mydłowska B; Zubkiewicz A; Szymczak M; Mysiak A; Skalik R
    Cardiol J; 2008; 15(2):162-8. PubMed ID: 18651401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S; Wright HM
    Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of nebivolol in patients with idiopathic pulmonary hypertension: results of the pilot study].
    Martyniuk TV; Konosova ID; Chazova IE
    Ter Arkh; 2012; 84(12):49-53. PubMed ID: 23479989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.